Arcutis Biotherapeutics, Inc. (ARQT) Tops Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts ARQT Hot Sheet
Join SI Premium – FREE
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) reported Q3 EPS of ($0.33), $0.09 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $44.75 million versus the consensus estimate of $37.62 million.
For earnings history and earnings-related data on Arcutis Biotherapeutics, Inc. (ARQT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aggreko files for proposed IPO
- Faraday Future cancels 237,615 warrants from March 2025 financing
- Oura said to be seeking up to $3 billion in IPO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
